CN1249000A - 细胞分离方法 - Google Patents
细胞分离方法 Download PDFInfo
- Publication number
- CN1249000A CN1249000A CN98802828A CN98802828A CN1249000A CN 1249000 A CN1249000 A CN 1249000A CN 98802828 A CN98802828 A CN 98802828A CN 98802828 A CN98802828 A CN 98802828A CN 1249000 A CN1249000 A CN 1249000A
- Authority
- CN
- China
- Prior art keywords
- cell
- liquid
- desire
- sequestration device
- pipeline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 63
- 239000007788 liquid Substances 0.000 claims abstract description 237
- 210000004027 cell Anatomy 0.000 claims description 596
- 230000009919 sequestration Effects 0.000 claims description 143
- 238000011084 recovery Methods 0.000 claims description 77
- 210000001772 blood platelet Anatomy 0.000 claims description 36
- 230000001413 cellular effect Effects 0.000 claims description 35
- 238000005204 segregation Methods 0.000 claims description 33
- 238000002955 isolation Methods 0.000 claims description 27
- 229920002307 Dextran Polymers 0.000 claims description 26
- 210000004700 fetal blood Anatomy 0.000 claims description 26
- 210000003995 blood forming stem cell Anatomy 0.000 claims description 24
- 210000001616 monocyte Anatomy 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 24
- 239000004744 fabric Substances 0.000 claims description 23
- 238000005138 cryopreservation Methods 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 19
- 238000004321 preservation Methods 0.000 claims description 19
- 239000004753 textile Substances 0.000 claims description 19
- 238000011144 upstream manufacturing Methods 0.000 claims description 16
- 238000007710 freezing Methods 0.000 claims description 15
- 230000008014 freezing Effects 0.000 claims description 13
- 239000002577 cryoprotective agent Substances 0.000 claims description 9
- 230000001681 protective effect Effects 0.000 claims description 9
- 210000005259 peripheral blood Anatomy 0.000 claims description 7
- 239000011886 peripheral blood Substances 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 6
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000815 hypotonic solution Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 25
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 25
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 239000002504 physiological saline solution Substances 0.000 description 17
- 210000000130 stem cell Anatomy 0.000 description 16
- 239000006285 cell suspension Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- -1 polyethylene Polymers 0.000 description 12
- 239000008103 glucose Substances 0.000 description 11
- 239000000835 fiber Substances 0.000 description 10
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000003999 initiator Substances 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 238000002054 transplantation Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 102000008100 Human Serum Albumin Human genes 0.000 description 8
- 108091006905 Human Serum Albumin Proteins 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 7
- 229920000728 polyester Polymers 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 239000012981 Hank's balanced salt solution Substances 0.000 description 6
- 239000004793 Polystyrene Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 229920000515 polycarbonate Polymers 0.000 description 5
- 239000004417 polycarbonate Substances 0.000 description 5
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000009169 immunotherapy Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- 229960004676 antithrombotic agent Drugs 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 230000009429 distress Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 210000003954 umbilical cord Anatomy 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 2
- OHYRGMMHMHDAKH-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate;2-hydroxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCO.CN(C)CCOC(=O)C(C)=C OHYRGMMHMHDAKH-UHFFFAOYSA-N 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- CGMRCMMOCQYHAD-UHFFFAOYSA-J dicalcium hydroxide phosphate Chemical compound [OH-].[Ca++].[Ca++].[O-]P([O-])([O-])=O CGMRCMMOCQYHAD-UHFFFAOYSA-J 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 210000003714 granulocyte Anatomy 0.000 description 2
- 210000002443 helper t lymphocyte Anatomy 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- VLCAYQIMSMPEBW-UHFFFAOYSA-N methyl 3-hydroxy-2-methylidenebutanoate Chemical compound COC(=O)C(=C)C(C)O VLCAYQIMSMPEBW-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 210000003887 myelocyte Anatomy 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 238000002205 phenol-chloroform extraction Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010024612 Lipoma Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000001120 cytoprotective effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- 238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 210000003924 normoblast Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000000247 postprecipitation Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011309 routine diagnosis Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 229960001814 trypan blue Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
- A61M1/3633—Blood component filters, e.g. leukocyte filters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
- C12N5/0692—Stem cells; Progenitor cells; Precursor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0439—White blood cells; Leucocytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
回收液(mPa·s) | 回收率(%) | 去除率(%) | |||
有核细胞 | 单核细胞 | CD34阳性细胞 | 红细胞 | 血小板 | |
A(10.5) | 75.2 | 90.2 | 97.0 | 99.0 | 88.0 |
B(8.0) | 74.0 | 90.0 | 96.6 | 99.0 | 88.0 |
C(5.3) | 73.0 | 89.6 | 95.5 | 99.0 | 88.0 |
回收液(mPa·s) | 回收率(%) | 去除率(%) | |||
有核细胞 | 单核细胞 | CD34阳性细胞 | 红细胞 | 血小板 | |
生理盐水(1.0) | 31.0 | 40.0 | 45.0 | 99.0 | 89.7 |
回收率(%) | 去除率(%) | |
白细胞 | 红细胞 | 血小板 |
75.0 | 99.1 | 90.3 |
回收率(%) | 去除率(%) | ||
CD34阳性细胞 | 红细胞 | 血小板 | CD34阴性细胞 |
78 | 99.2 | 90.4 | 90 |
回收率(%) | 去除率(%) | 纯化DNA量(μg) | |||
有核细胞 | 单核细胞 | CD34阳性细胞 | 红细胞 | 血小板 | |
75.0 | 90.4 | 97.2 | 98.9 | 88.3 | 9.8 |
回收率(%) | 去除率(%) | |||
有核细胞 | 单核细胞 | CD34阳性细胞 | 红细胞 | 血小板 |
74.3 | 91.2 | 97.6 | 99.0 | 88.0 |
Claims (41)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP024517/1997 | 1997-01-24 | ||
JP02451797A JP4412621B2 (ja) | 1997-01-24 | 1997-01-24 | 細胞分離方法 |
JP24517/1997 | 1997-01-24 | ||
JP054300/1997 | 1997-02-24 | ||
JP54300/1997 | 1997-02-24 | ||
JP9054300A JPH10234361A (ja) | 1997-02-24 | 1997-02-24 | 造血幹細胞分離・保存システム |
JP143002/97 | 1997-05-19 | ||
JP143002/1997 | 1997-05-19 | ||
JP14300297A JP3938973B2 (ja) | 1997-05-19 | 1997-05-19 | 細胞分離方法 |
PCT/JP1998/000244 WO1998032840A1 (fr) | 1997-01-24 | 1998-01-22 | Procede de separation des cellules |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1249000A true CN1249000A (zh) | 2000-03-29 |
CN1330752C CN1330752C (zh) | 2007-08-08 |
Family
ID=27284685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB98802828XA Expired - Lifetime CN1330752C (zh) | 1997-01-24 | 1998-01-22 | 细胞分离方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US6268119B1 (zh) |
EP (1) | EP0987325B1 (zh) |
CN (1) | CN1330752C (zh) |
AT (1) | ATE509094T1 (zh) |
AU (1) | AU731766B2 (zh) |
CA (1) | CA2278208C (zh) |
WO (1) | WO1998032840A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1112442C (zh) * | 2000-06-14 | 2003-06-25 | 华东理工大学 | 细胞灌注培养过程中的细胞截留分离方法及其装置 |
CN1301327C (zh) * | 2003-09-25 | 2007-02-21 | 中山大学肿瘤防治中心 | 人肿瘤细胞的分离纯化方法 |
CN102971411A (zh) * | 2010-07-01 | 2013-03-13 | 株式会社钟化 | 细胞培养用一次性器具、细胞培养装置及细胞制备方法 |
CN103228780A (zh) * | 2010-11-25 | 2013-07-31 | 株式会社钟化 | 白细胞或单核细胞的分离方法、分离材 |
CN103555559A (zh) * | 2007-03-28 | 2014-02-05 | 热起源公司 | 从骨髓或脐带血回收的干细胞和祖细胞组合物;用于制备其的系统和方法 |
CN105524881A (zh) * | 2016-01-20 | 2016-04-27 | 南京三生生物技术有限公司 | 动物淋巴细胞分离液及其制备方法 |
CN110283782A (zh) * | 2019-06-27 | 2019-09-27 | 昆明医科大学第二附属医院 | 一种人骨髓间充质干细胞株的建立方法和诱导分化应用 |
CN113980894A (zh) * | 2021-12-27 | 2022-01-28 | 深圳博雅感知医疗科技有限公司 | 制备骨髓浓缩细胞的方法及其用于治疗卵巢早衰的用途 |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE329012T1 (de) * | 1997-04-08 | 2006-06-15 | Pall Corp | Verfahren zur gewinnung von seltenen zellen aus blutprodukten |
DE19912120A1 (de) * | 1999-03-18 | 2000-09-28 | Fraunhofer Ges Forschung | Verfahren zur Isolierung von Erythrozyten |
EP1214037B1 (en) | 1999-09-16 | 2004-04-07 | Vasogen Ireland Limited | Apparatus for conditioning mammalian blood |
US6670128B2 (en) * | 2000-08-16 | 2003-12-30 | Whatman, Inc. | Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies |
IL158171A0 (en) * | 2001-04-10 | 2004-03-28 | Bioergonomics Inc | Compositions and methods for cell separation |
GB2392116A (en) * | 2001-05-31 | 2004-02-25 | Asahi Chemical Ind | Method of separating and concentrating cells for kidney regeneration |
WO2003027247A2 (en) | 2001-09-24 | 2003-04-03 | Sangamo Biosciences, Inc. | Modulation of stem cells using zinc finger proteins |
US7514075B2 (en) | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
US8105580B2 (en) | 2001-12-07 | 2012-01-31 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to promote wound healing |
US7651684B2 (en) | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
KR101083454B1 (ko) | 2001-12-07 | 2011-11-16 | 사이토리 테라퓨틱스, 인크. | 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한 시스템 및 방법 |
US7595043B2 (en) | 2001-12-07 | 2009-09-29 | Cytori Therapeutics, Inc. | Method for processing and using adipose-derived stem cells |
US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US8404229B2 (en) | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US7291450B2 (en) | 2003-03-28 | 2007-11-06 | Smith & Nephew, Inc. | Preparation of a cell concentrate from a physiological solution |
US20050032097A1 (en) * | 2003-06-17 | 2005-02-10 | Garvin Alex M. | Method for processing samples containing sperm and non-sperm cells for subsequent analysis of the sperm DNA |
WO2005035737A1 (ja) * | 2003-10-10 | 2005-04-21 | Asahi Kasei Medical Co., Ltd. | 細胞濃縮物の調製方法および細胞組成物 |
GB2420976B (en) * | 2004-11-19 | 2006-12-20 | Zvi Finkelstein | Therapeutic implant |
US20060228734A1 (en) * | 2005-03-18 | 2006-10-12 | Applera Corporation | Fluid processing device with captured reagent beads |
US20100016830A1 (en) * | 2006-04-28 | 2010-01-21 | Ellsworth James R | Injection of Anticoagulant Into Bone Marrow Space |
US8067151B2 (en) * | 2007-02-09 | 2011-11-29 | Canadian Blood Services | Cold storage of pegylated platelets at about or below 0° C. |
US7964339B2 (en) * | 2007-02-09 | 2011-06-21 | Canadian Blood Services | Cold storage of modified platelets |
JP5243456B2 (ja) * | 2007-03-02 | 2013-07-24 | スミス アンド ネフュー ピーエルシー | 生物学的サンプルろ過中の超音波、逆流洗浄、およびフィルタ運動によるフィルタ洗浄装置および方法 |
JP5330996B2 (ja) * | 2007-08-23 | 2013-10-30 | 国立大学法人 新潟大学 | ヒト骨膜培養方法 |
KR101672063B1 (ko) | 2008-07-25 | 2016-11-16 | 스미쓰 앤드 네퓨 피엘씨 | 유체 샘플로부터 고체 부분을 분리하는 분리 장치 및 분리 방법 |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
JP5917392B2 (ja) | 2009-05-01 | 2016-05-11 | ビミニ テクノロジーズ リミテッド ライアビリティ カンパニー | 組織及び細胞富化グラフトを最適化するシステム、方法及び組成物 |
EP2450431B1 (en) | 2009-06-30 | 2020-01-01 | Kaneka Corporation | Blood component separation system and separation material |
SE0951009A1 (sv) * | 2009-12-22 | 2011-06-23 | Anordning och förfarande för rening och anrikning av biologiskt prov | |
JP2012120458A (ja) * | 2010-12-06 | 2012-06-28 | Kaneka Corp | 細胞の分離器具。 |
US9421317B2 (en) | 2012-06-08 | 2016-08-23 | Pall Corporation | Cell harvesting device and system |
US9427512B2 (en) | 2012-06-08 | 2016-08-30 | Pall Corporation | Filter device |
US9102918B2 (en) | 2013-01-31 | 2015-08-11 | Biomet Biologics, Llc | Methods for rejuvenating red blood cells |
US9011408B2 (en) * | 2013-01-31 | 2015-04-21 | Biomet Biologics, Llc | Functionally-closed, sterile blood processing solution system and method |
US9103842B2 (en) | 2013-01-31 | 2015-08-11 | Biomet Biologics, Llc | Methods for rejuvenating red blood cells |
US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
US11493428B2 (en) | 2013-03-15 | 2022-11-08 | Gpb Scientific, Inc. | On-chip microfluidic processing of particles |
US10324011B2 (en) | 2013-03-15 | 2019-06-18 | The Trustees Of Princeton University | Methods and devices for high throughput purification |
US10976232B2 (en) | 2015-08-24 | 2021-04-13 | Gpb Scientific, Inc. | Methods and devices for multi-step cell purification and concentration |
EP3301445B1 (en) | 2016-09-30 | 2020-03-18 | ARKRAY, Inc. | Method for magnetically labeling particles |
US10940248B2 (en) * | 2016-12-19 | 2021-03-09 | Fenwal, Inc. | Systems and methods for recovering white blood cells from a leukoreduction filter |
EP3675876A4 (en) | 2017-09-01 | 2021-06-02 | GPB Scientific, Inc. | PROCESSES FOR PREPARING THERAPEUTICALLY ACTIVE CELLS USING MICROFLUIDICS |
CN110551686A (zh) * | 2019-09-05 | 2019-12-10 | 广东唯泰生物科技有限公司 | 外周血单个核细胞的分离方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5854125B2 (ja) | 1978-03-06 | 1983-12-02 | 旭化成株式会社 | 白血球分離フイルタ−と白血球分離方法 |
JPS5854128B2 (ja) * | 1978-03-06 | 1983-12-02 | 旭化成株式会社 | リンパ球の分離方法およびその装置 |
US4255267A (en) * | 1979-11-02 | 1981-03-10 | E. I. Du Pont De Nemours And Company | Separation and recovery of granulocytes from blood using adherence on an expandable bed of a polymeric material |
FR2484077B1 (fr) * | 1980-06-06 | 1984-07-06 | Inst Nat Sante Rech Med | Procede et dispositif de mesure de la deformabilite de cellules vivantes, notamment des globules rouges du sang |
JPS61235752A (ja) | 1985-04-11 | 1986-10-21 | Asahi Optical Co Ltd | 細胞分離材、分離器および分離方法 |
US4865733A (en) * | 1986-03-22 | 1989-09-12 | Toa Nenryo Kogyo K.K. | Cell separator device |
JPS645486A (en) * | 1987-06-29 | 1989-01-10 | Hitachi Ltd | Cell culture method and apparatus therefor |
US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
JPH02200176A (ja) * | 1989-01-30 | 1990-08-08 | Hitachi Ltd | 細胞培養方法及びその装置 |
JP2817934B2 (ja) * | 1989-02-28 | 1998-10-30 | 旭光学工業株式会社 | 細胞分離材及び分離器 |
SE9000650L (sv) | 1989-02-28 | 1990-08-29 | Asahi Optical Co Ltd | Separation av celler eller virus |
JP3315796B2 (ja) | 1993-12-27 | 2002-08-19 | テルモ株式会社 | 臍帯血採取装置 |
US5629186A (en) * | 1994-04-28 | 1997-05-13 | Lockheed Martin Corporation | Porous matrix and method of its production |
US6017719A (en) * | 1994-06-14 | 2000-01-25 | Nexell Therapeutics, Inc. | Positive and positive/negative cell selection mediated by peptide release |
JPH0869A (ja) | 1994-06-23 | 1996-01-09 | Mitsubishi Agricult Mach Co Ltd | コンバインにおけるカッター装置の安全構造 |
JPH0852206A (ja) | 1994-08-16 | 1996-02-27 | Terumo Corp | 臍帯血採取装置および臍帯血採取器具 |
JPH0892001A (ja) * | 1994-09-26 | 1996-04-09 | Asahi Medical Co Ltd | 細胞集団の保存方法 |
JPH08104643A (ja) | 1994-10-05 | 1996-04-23 | Asahi Medical Co Ltd | 赤血球除去方法 |
US5647985A (en) * | 1994-10-17 | 1997-07-15 | Baxter International Inc. | Whole blood leukodepletion and platelet filter |
US5789147A (en) | 1994-12-05 | 1998-08-04 | New York Blood Center, Inc. | Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood |
WO1997041899A1 (en) * | 1996-05-03 | 1997-11-13 | Innogenetics N.V. | New medicaments containing gelatin cross-linked with oxidized polysaccharides |
JPH09322758A (ja) * | 1996-05-31 | 1997-12-16 | Asahi Medical Co Ltd | 体外増幅に適した細胞分離システムおよび分離方法 |
-
1998
- 1998-01-22 AU AU55763/98A patent/AU731766B2/en not_active Expired
- 1998-01-22 CA CA2278208A patent/CA2278208C/en not_active Expired - Lifetime
- 1998-01-22 US US09/341,879 patent/US6268119B1/en not_active Expired - Lifetime
- 1998-01-22 AT AT98900701T patent/ATE509094T1/de not_active IP Right Cessation
- 1998-01-22 EP EP98900701A patent/EP0987325B1/en not_active Expired - Lifetime
- 1998-01-22 CN CNB98802828XA patent/CN1330752C/zh not_active Expired - Lifetime
- 1998-01-22 WO PCT/JP1998/000244 patent/WO1998032840A1/ja active IP Right Grant
-
2001
- 2001-06-04 US US09/871,645 patent/US20010036624A1/en not_active Abandoned
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1112442C (zh) * | 2000-06-14 | 2003-06-25 | 华东理工大学 | 细胞灌注培养过程中的细胞截留分离方法及其装置 |
CN1301327C (zh) * | 2003-09-25 | 2007-02-21 | 中山大学肿瘤防治中心 | 人肿瘤细胞的分离纯化方法 |
CN103555559A (zh) * | 2007-03-28 | 2014-02-05 | 热起源公司 | 从骨髓或脐带血回收的干细胞和祖细胞组合物;用于制备其的系统和方法 |
CN103555559B (zh) * | 2007-03-28 | 2015-04-22 | 热起源公司 | 从骨髓或脐带血回收的干细胞和祖细胞组合物;用于制备其的系统和方法 |
CN102971411A (zh) * | 2010-07-01 | 2013-03-13 | 株式会社钟化 | 细胞培养用一次性器具、细胞培养装置及细胞制备方法 |
CN102971411B (zh) * | 2010-07-01 | 2016-07-06 | 株式会社钟化 | 细胞培养用一次性器具、细胞培养装置及细胞制备方法 |
CN103228780A (zh) * | 2010-11-25 | 2013-07-31 | 株式会社钟化 | 白细胞或单核细胞的分离方法、分离材 |
CN103228780B (zh) * | 2010-11-25 | 2015-04-15 | 株式会社钟化 | 白细胞或单核细胞的分离方法、分离材 |
CN105524881A (zh) * | 2016-01-20 | 2016-04-27 | 南京三生生物技术有限公司 | 动物淋巴细胞分离液及其制备方法 |
CN105524881B (zh) * | 2016-01-20 | 2019-01-11 | 南京三生生物技术股份有限公司 | 动物淋巴细胞分离液及其制备方法 |
CN110283782A (zh) * | 2019-06-27 | 2019-09-27 | 昆明医科大学第二附属医院 | 一种人骨髓间充质干细胞株的建立方法和诱导分化应用 |
CN113980894A (zh) * | 2021-12-27 | 2022-01-28 | 深圳博雅感知医疗科技有限公司 | 制备骨髓浓缩细胞的方法及其用于治疗卵巢早衰的用途 |
Also Published As
Publication number | Publication date |
---|---|
EP0987325B1 (en) | 2011-05-11 |
AU731766B2 (en) | 2001-04-05 |
EP0987325A4 (en) | 2003-02-05 |
CA2278208C (en) | 2011-09-20 |
EP0987325A1 (en) | 2000-03-22 |
CN1330752C (zh) | 2007-08-08 |
CA2278208A1 (en) | 1998-07-30 |
AU5576398A (en) | 1998-08-18 |
WO1998032840A1 (fr) | 1998-07-30 |
US6268119B1 (en) | 2001-07-31 |
US20010036624A1 (en) | 2001-11-01 |
ATE509094T1 (de) | 2011-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1249000A (zh) | 细胞分离方法 | |
CN103228780B (zh) | 白细胞或单核细胞的分离方法、分离材 | |
JP4587959B2 (ja) | 細胞濃縮物の調製方法および細胞組成物 | |
JP2007289076A (ja) | 脂肪組織から幹細胞を採取するのに適した細胞分離装置、およびその方法 | |
CN1729027A (zh) | 用于去除白细胞的方法、白细胞除去过滤器及其使用 | |
CN1658940A (zh) | 细胞分离组合物和方法 | |
US20040152190A1 (en) | Method of separating and concentrating cells for kidney regfneration | |
JP5800797B2 (ja) | 細胞濃縮・回収方法及び細胞回収液 | |
US20020031757A1 (en) | Method of regenerating a tissue | |
JPH114682A (ja) | 有核細胞保存方法、有核細胞保存用組成物及び有核細胞分離方法 | |
JP4245324B2 (ja) | 単球の分離回収方法 | |
JP6169972B2 (ja) | 幹細胞分離方法 | |
JPH11322618A (ja) | 有核細胞分離回収方法及び有核細胞含有液 | |
JP2004121144A (ja) | 単核球の採取方法 | |
JP3938973B2 (ja) | 細胞分離方法 | |
JPH11335289A (ja) | 血小板除去方法及び細胞組成物 | |
JP4036304B2 (ja) | 細胞捕捉・回収方法 | |
JP4412621B2 (ja) | 細胞分離方法 | |
JP2000139454A (ja) | 細胞分離回収方法及び回収必要細胞含有液 | |
JPH119270A (ja) | 有核細胞分離回収方法および有核細胞分離回収器 | |
JP2001017162A (ja) | 凍結解凍細胞の細胞洗浄方法及び細胞洗浄装置 | |
JP2001078757A (ja) | 細胞分離方法及び細胞分離用流体 | |
JP2003116521A (ja) | Sp細胞の分離濃縮方法及び装置 | |
JPH09322758A (ja) | 体外増幅に適した細胞分離システムおよび分離方法 | |
JPH11266852A (ja) | 細胞分離器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: Tokyo, Japan, Japan Patentee after: Asahi Kasei Kuraray Medical Co. Address before: Tokyo, Japan, Japan Patentee before: Asahi Kasei Medical Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: ASAHI KASEI MEDICAL CO., LTD. Free format text: FORMER OWNER: ASAHI KASEI KURARAY MEDICAL CO., LTD. Effective date: 20120724 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120724 Address after: Tokyo, Japan Patentee after: Asahi Kasei Medical Co., Ltd. Address before: Tokyo, Japan, Japan Patentee before: Asahi Kasei Kuraray Medical Co. |
|
CX01 | Expiry of patent term |
Granted publication date: 20070808 |
|
CX01 | Expiry of patent term |